Aggregation The role of prior infection in the vaccine trials Kaiser reviews a finding from the J&J vaccine trial about immunity from infection.
vaccine effectiveness Cutting infection rate by half is not the same as protecting half the people from infection Kaiser explains what 50% vaccine efficacy actually means, and it's not what you think.
